Myocardial infarction following administration of sublingual ergotamine.
D000284:Administration, Oral; D000328:Adult; D004878:Ergotamine / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008881:Migraine Disorders / Q000188:drug therapy; D009060:Mouth Floor; D009203:Myocardial Infarction / Q000139:chemically induced*
D004878:Ergotamine